Physician profile
Alan J Meltzer
NPI 1164427894
$1,834.82
in general payments reported to CMS, 2019-2025
13 companies · $304 in 2025
The $304 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $196 · 2020: $11.33 · 2021: $127 · 2022: $344 · 2023: $320 · 2024: $533 · 2025: $304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,156.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $741.57 | 2019-2025 | Collagenase Santyl |
| Organogenesis INC. | $407.51 | 2019-2025 | Apligraf, Puraply |
| Henry Schein, INC. | $161.87 | 2025 | Nuoss, Ace Surgical Supply, Allooss Allograft Putty |
| Abbvie INC. | $118.02 | 2024 | |
| Kerecis Limited | $89.57 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Solventum Corporation | $72.57 | 2024 | Activ.A.C., 3m Coban |
| Kci USA, INC. | $68.50 | 2022-2023 | Activ.A.C. |
| Next Science LLC | $47.52 | 2023 | Xperience, Blastx, Surgx |
| Integra Lifesciences Corporation | $47.40 | 2019-2024 | Tcc-Ez |
| Bsn Medical INC | $38.19 | 2024 | |
| Mimedx Group, INC. | $17.33 | 2025 | |
| Geistlich Pharma, North America, INC. | $13.07 | 2019 | |
| Misonix INC | $11.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Meltzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.